Overall, BD is expected to increase its production of domestically manufactured safety-engineered injection devices by more than 40% and conventional syringes by more than 50%. The manufacturer has hired over 215 staffers in Nebraska and Connecticut to support the effort.

Becton Dickinson (BDX) announced additional investments in its U.S. manufacturing network to add capacity for medical devices, including